Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Current Opinion in Microbiology|October 1, 2008
Challenges facing drug development for malariaJ Carl Craft
Travel Medicine and Infectious Disease|February 13, 2007
Medicines for Malaria Venture new developments in antimalarialsSolomon Nwaka, Lise Riopel, David Ubben, et al.
Antimicrobial Agents and Chemotherapy|November 16, 2011
In vitro and in vivo activity of solithromycin (CEM-101) against Plasmodium speciesSergio Wittlin, Eric Ekland, J Carl Craft, et al.
Reproductive Toxicology (Elmsford, N.Y.)|August 17, 2010
Comparative embryotoxicity of different antimalarial peroxides: in vitro study using the rat whole embryo culture model (WEC)Monica Longo, Sara Zanoncelli, Marco Brughera, et al.
Antimicrobial Agents and Chemotherapy|March 20, 2013
Randomized, double-blind, multicenter phase 2 study comparing the efficacy and safety of oral solithromycin (CEM-101) to those of oral levofloxacin in the treatment of patients with community-acquired bacterial pneumoniaDavid Oldach, Kay Clark, Jennifer Schranz, et al.
Malaria Journal|December 22, 2009
Population pharmacokinetics of artesunate and dihydroartemisinin following single- and multiple-dosing of oral artesunate in healthy subjectsBeesan Tan, Himanshu Naik, In-Jin Jang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 7, 2011
A randomized, double-blind phase 2 study comparing the efficacy and safety of an oral fusidic acid loading-dose regimen to oral linezolid for the treatment of acute bacterial skin and skin structure infectionsJ Carl Craft, Susan R Moriarty, Kay Clark, et al.
Malaria Journal|August 11, 2012
Review of pyronaridine anti-malarial properties and product characteristicsSimon L Croft, Stephan Duparc, Sarah J Arbe-Barnes, et al.
British Journal of Clinical Pharmacology|July 5, 2012
First-in-man safety and pharmacokinetics of synthetic ozonide OZ439 demonstrates an improved exposure profile relative to other peroxide antimalarialsJoerg J Moehrle, Stephan Duparc, Christoph Siethoff, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 9, 2011
Synthetic ozonide drug candidate OZ439 offers new hope for a single-dose cure of uncomplicated malariaSusan A Charman, Sarah Arbe-Barnes, Ian C Bathurst, et al.
Pageof 1